The global radiofrequency balloon catheter market, valued at USD 50 billion in 2022, is set for a remarkable growth trajectory, with an estimated Compound Annual Growth Rate (CAGR) of 5.5% between 2022 and 2032. This surge in market growth comes in the wake of the increasing prevalence of cardiovascular diseases, notably atrial fibrillation, driven by the growing incidence of sedentary lifestyles worldwide.
Atrial fibrillation, once an overlooked condition, has now emerged as a significant cause of concern due to its potential to lead to fatal complications. However, radiofrequency balloon catheters are providing a much-needed solution to address this challenge. These advanced devices are becoming integral to the diagnosis and treatment of atrial fibrillation, offering improved safety and reliability during pulmonary isolation procedures.
Radiofrequency balloon catheters work by utilizing radiofrequency energy to heat tissue around the pulmonary veins, creating circular scars that help prevent abnormal electrical activity. The technique involves the movement of the catheter from the femoral vein to the left atrium, where it performs precise tissue ablation. Notably, these catheters provide a higher Safety Quotient (SQ), which has been a driving factor in their increasing adoption in cardiac care.
The latest advancements in radiofrequency balloon catheters include the integration of multi-electrode saline-irrigated technology, equipped with a camera system to perform single-shot pulmonary vein isolation. This innovative feature allows circumferential RF energy to be delivered for optimal ablation, with power output tailored to each electrode based on real-time tissue-electrode contact.
Despite the strong growth prospects, challenges remain. The reproducibility rate of radiofrequency balloon catheters is lower compared to cryoballoon catheters, which could hinder broader adoption. Additionally, the higher cost of radiofrequency balloon catheters compared to alternatives may limit their accessibility in certain markets.
According to an analyst at Future Market Insights, “With atrial fibrillation becoming an increasingly prevalent issue globally, the radiofrequency balloon catheter market is poised for substantial growth in the coming years. These advanced catheters are helping improve patient outcomes, making them a critical tool in the fight against cardiovascular diseases.”
Future Market Insights, a leading market research firm, offers a comprehensive study of the radiofrequency balloon catheter market, providing valuable insights through a 360-degree analysis, encompassing primary, secondary, and tertiary research. The study highlights the potential for innovation and growth in this sector, underscoring the increasing importance of radiofrequency balloon catheters in modern cardiac care.
Key Takeaways from Radiofrequency Balloon Catheter Market:
- North America holds the largest market share owing to new/advanced technologies being increasingly adopted all across the US. Also, the fact that the US and Canada are turning out to be hubs of chronic ailments can’t be ignored. The CDC states that cardiac ailments contribute for 25% of fatalities in the US every single year. This could be reasoned with physical inactivity, poor diet, smoking, excessive intake of alcohol, higher levels of cholesterol, hypertension, and likewise. IHME report has also stated that ischemic heart disease is amongst the leading causes of disability and death in Canada. As such, growing occurrences of artery disease and occlusions in the blood vessels could bolster the radiofrequency balloon catheter market going forward.
- Europe is expected to grow inadvertently in the radiofrequency balloon catheter market going forward owing to increasing incidences of atrial fibrillation.
- The Asia-Pacific is expected to grow at a rapid pace in the radiofrequency balloon catheter market due to growing awareness amongst the people regarding importance of early diagnosis. Japan is at the forefront in this regard and expected to be followed by countries like India in the forecast period.
Elevated Market Interest: Delve into In-Depth Trends and Insights with Our Full Report!
Competitive Catheters:
- Biosense Webster, Inc., of late, has come up with multi-electrode radiofrequency balloon catheter to treat symptomatic paroxysmal atrial fibrillation.
- Barrx 360 express RFA balloon catheter from Medtronic does feature self-adjusting ablation balloon that does away with sizing process, thereby rendering simpler and more efficient course of treatment.
What does the Report get into?
- The research study is based on indication (chronic hemorrhagic radiation proctitis and malignant biliary strictures), and by end-user (clinics, hospitals, diagnostic laboratories, and likewise).
- With growing incidences of pulmonary vein isolation and atrial fibrillation, the global radiofrequency balloon catheter market is bound to grow on a substantial note in the forecast period.
Key Companies Profiled:
- Medtronic
- Biosense Webster, Inc
Key Segments Profiled in the Radiofrequency Balloon Catheter Market Survey
By Indication:
- Chronic hemorrhagic radiation proctitis
- Malignant biliary strictures
By End User:
- Hospitals
- Clinics
- Diagnostics Laboratories
- Others
By Region:
- North America (USA, Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- The Middle East and Africa (GCC Countries, S. Africa, N. Africa)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
